Prevalence and incidence of systemic sclerosis in southern Sweden: Population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria

Annals of the Rheumatic Diseases

Volumn 73, Issue 10, 2014, Pages 1788-1792

  Andreasson K ^a,b   Saxne, T ^a   Bergknut, C ^a,b   Hesselstrand, R ^a   Englund, M ^a,b,c  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY HOSPITAL   (Sweden)

^c BOSTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY;

ADULT; AGE DISTRIBUTION; AGED; BLOOD; FEMALE; HUMAN; IMMUNOLOGY; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; REGISTER; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX RATIO; SWEDEN;

ADULT; AGE DISTRIBUTION; AGED; AUTOANTIBODIES; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PREVALENCE; REGISTRIES; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SEX DISTRIBUTION; SWEDEN;

EID: 84881129052     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2013-203618     Document Type: Article

References (33)

1. Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med 2009;360:1989-2003.
2. Silman A, Jannini S, Symmons D, et al. An epidemiological study of scleroderma in the West Midlands. Br J Rheumatol 1988;27:286-90.
3. Kaipiainen-Seppanen O, Aho K. Incidence of rare systemic rheumatic and connective tissue diseases in Finland. J Intern Med 1996;240:81-4.
4. Hoffmann-Vold AM, Midtvedt O, Molberg O, et al. Prevalence of systemic sclerosis in south-east Norway. Rheumatology (Oxford) 2012;51:1600-5.
5. Geirsson AJ, Steinsson K, Guthmundsson S, et al. Systemic sclerosis in Iceland. A nationwide epidemiological study. Ann Rheum Dis 1994;53:502-5.
6. Asboe-Hansen G. Epidemiology of progressive systemic sclerosis. In: Black C, Myers A. eds. Progressive systemic sclerosis (current topics in rheumatology). New York: Gower Medical Publishing, 1985:88.
7. Allcock RJ, Forrest I, Corris PA, et al. A study of the prevalence of systemic sclerosis in northeast England. Rheumatology (Oxford) 2004;43:596-602.
8. Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991;283:366-71.
9. Mayes MD, Lacey JV, Beebe-Dimmer J, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003;48:2246-55.
10. Maricq HR, Weinrich MC, Keil JE, et al. Prevalence of scleroderma spectrum disorders in the general population of South Carolina. Arthritis Rheum 1989;32:998-1006.
11. Bernatsky S, Joseph L, Pineau CA, et al. Scleroderma prevalence: demographic variations in a population-based sample. Arthritis Rheum 2009;61:400-4.
12. Alamanos Y, Tsifetaki N, Voulgari PV, et al. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002. Semin Arthritis Rheum 2005;34:714-20.
13. Arias-Nunez MC, Llorca J, Vazquez-Rodriguez TR, et al. Systemic sclerosis in northwestern Spain: a 19-year epidemiologic study. Medicine (Baltimore) 2008;87:272-80.
14. Le Guern V, Mahr A, Mouthon L, et al. Prevalence of systemic sclerosis in a French multi-ethnic county. Rheumatology (Oxford) 2004;43:1129-37.
15. Radic M, Martinovic Kaliterna D, Fabijanic D, et al. Prevalence of systemic sclerosis in Split-Dalmatia county in southern Croatia. Clin Rheumatol 2010;29:419-21.
16. Roberts-Thomson PJ, Walker JG, Lu TY, et al. Scleroderma in South Australia: further epidemiological observations supporting a stochastic explanation. Intern Med J 2006;36:489-97.
17. Chifflot H, Fautrel B, Sordet C, et al. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008;37:223-35.
18. Thompson AE, Pope JE. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis. J Rheumatol 2002;29:1867-73.
19. Hachulla E, Launay D. Diagnosis and classification of systemic sclerosis. Clin Rev Allergy Immunol 2011;40:78-83.
20. American Rheumatism Association. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
21. Lonzetti LS, Joyal F, Raynauld JP, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001;44:735-6.
22. Fransen J, Johnson SR, van den Hoogen F, et al. Items for developing revised classification criteria in systemic sclerosis: results of a consensus exercise. Arthritis Care Res (Hoboken) 2012;64:351-7.
23. Johnson SR, Fransen J, Khanna D, et al. Validation of potential classification criteria for systemic sclerosis. Arthritis Care Res (Hoboken) 2012;64:358-67.
24. Johnson SR, Naden RP, Fransen J, et al. Systemic sclerosis classification criteria: developing methods for multi-criteria decision analysis [abstract]. Arthritis Rheum 2012;64(Suppl 10):853.
25. Englund M, Jöud A, Geborek P, et al. Prevalence and incidence of rheumatoid arthritis in southern Sweden 2008 and their relation to prescribed biologics. Rheumatology (Oxford) 2010;49:1563-9.
26. Haglund E, Bremander AB, Petersson IF, et al. Prevalence of spondyloarthritis and its subtypes in southern Sweden. Ann Rheum Dis 2011;70:943-8.
27. Anell A, Glenngård AH, Merkur S. Sweden health system review. Health Syst Transit 2012;14:1-159.
28. Statistics Sweden. Statistiska centralbyrån 2012. http://www.scb.se (accessed 18 July 2013).
29. LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988;15:202-5.
30. Wollheim FA. Classification of systemic sclerosis. Visions and reality. Rheumatology (Oxford) 2005;44:1212-16.
31. Hunzelmann N, Genth E, Krieg T, et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford) 2008;47:1185-92.
32. Hesselstrand R, Scheja A, Wildt M, et al. High-frequency ultrasound of skin involvement in systemic sclerosis reflects oedema, extension and severity in early disease. Rheumatology (Oxford) 2008;47:84-7.
33. Mierau R, Moinzadeh P, Riemekasten G, et al. Frequency of disease-associated and other nuclear autoantibodies in patients of the German Network for Systemic Scleroderma: correlation with characteristic clinical features. Arthritis Res Ther 2011;13:R172.